...
首页> 外文期刊>Bioinformatics >CNAnova: a new approach for finding recurrent copy number abnormalities in cancer SNP microarray data
【24h】

CNAnova: a new approach for finding recurrent copy number abnormalities in cancer SNP microarray data

机译:CNAnova:在癌症SNP微阵列数据中发现重复拷贝数异常的新方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Motivation: The current generation of single nucleotide polymorphism (SNP) arrays allows measurement of copy number aberrations (CNAs) in cancer at more than one million locations in the genome in hundreds of tumour samples. Most research has focused on single-sample CNA discovery, the so-called segmentation problem. The availability of high-density, large sample-size SNP array datasets makes the identification of recurrent copy number changes in cancer, an important issue that can be addressed using the cross-sample information.Results: We present a novel approach for finding regions of recurrent copy number aberrations, called CNAnova, from Affymetrix SNP 6.0 array data. The method derives its statistical properties from a control dataset composed of normal samples and, in contrast to previous methods, does not require segmentation and permutation steps. For rigorous testing of the algorithm and comparison to existing methods, we developed a simulation scheme that uses the noise distribution present in Affymetrix arrays. Application of the method to 128 acute lymphoblastic leukaemia samples shows that CNAnova achieves lower error rate than a popular alternative approach. We also describe an extension of the CNAnova framework to identify recurrent CNA regions with intra-tumour heterogeneity, present in either primary or relapsed samples from the same patients.
机译:动机:当前一代的单核苷酸多态性(SNP)阵列允许在数百个肿瘤样本中基因组中超过一百万个位置的癌症中测量拷贝数畸变(CNA)。大多数研究都集中在单样本CNA发现上,即所谓的分割问题。高密度,大样本大小的SNP阵列数据集的可用性使人们能够识别癌症中复发拷贝数的变化,这是可以使用交叉样本信息解决的重要问题。结果:我们提出了一种新颖的方法来寻找来自Affymetrix SNP 6.0阵列数据的循环拷贝数异常,称为CNAnova。该方法从包含正常样本的控制数据集中获取其统计属性,与以前的方法相比,该方法不需要分割和置换步骤。为了对算法进行严格测试并与现有方法进行比较,我们开发了一种模拟方案,该方案使用了Affymetrix阵列中存在的噪声分布。该方法在128例急性淋巴细胞白血病样本中的应用表明,与流行的替代方法相比,CNAnova的错误率更低。我们还描述了CNAnova框架的扩展,以鉴定具有相同的患者原发性或复发性样品中存在的肿瘤内异质性的复发性CNA区。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号